ABN Amro Investment Solutions Purchases 17,007 Shares of Veeva Systems Inc. $VEEV

ABN Amro Investment Solutions grew its position in Veeva Systems Inc. (NYSE:VEEV) by 28.4% during the fourth quarter, HoldingsChannel.com reports. The fund owned 76,809 shares of the technology company’s stock after acquiring an additional 17,007 shares during the quarter. ABN Amro Investment Solutions’ holdings in Veeva Systems were worth $17,146,000 at the end of the most recent reporting period.

Other large investors have also recently modified their holdings of the company. Jensen Investment Management Inc. increased its position in shares of Veeva Systems by 1,924.5% during the 3rd quarter. Jensen Investment Management Inc. now owns 413,213 shares of the technology company’s stock valued at $123,100,000 after purchasing an additional 392,802 shares during the last quarter. Alphinity Investment Management Pty Ltd bought a new position in shares of Veeva Systems during the 3rd quarter valued at approximately $422,241,000. Principal Financial Group Inc. increased its position in shares of Veeva Systems by 11.2% during the 3rd quarter. Principal Financial Group Inc. now owns 3,846,877 shares of the technology company’s stock valued at $1,146,040,000 after purchasing an additional 388,864 shares during the last quarter. Compass Wealth Management LLC bought a new position in shares of Veeva Systems during the 3rd quarter valued at approximately $18,694,000. Finally, ABN AMRO Bank N.V. bought a new position in shares of Veeva Systems during the 3rd quarter valued at approximately $246,625,000. Institutional investors own 88.20% of the company’s stock.

Trending Headlines about Veeva Systems

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Investor sentiment improved after Michael Burry was reported to hold a position in Veeva Systems, adding a high-profile endorsement for the stock. Veeva Systems Inc. (VEEV): Michael Burry Admires This Software Stock
• Positive Sentiment: Multiple articles highlighted Veeva’s RTSM momentum, major pharma wins, and durable long-term growth drivers in clinical software, reinforcing the bull case for the business. Veeva Systems’ RTSM Momentum Signals Another Long-Term Growth Driver
• Positive Sentiment: Coverage also framed Veeva as a strong growth stock with healthy fundamentals and long-term investor appeal, which can help support the shares. Here's Why Veeva Systems (VEEV) is a Strong Growth Stock
• Neutral Sentiment: Another article repeated the argument that Veeva has strong long-term growth potential and is attracting institutional interest, but it was largely reiterative rather than a new catalyst. Long-Term Growth Potential Driving Investor Interest In Veeva Systems Inc. (VEEV)
• Neutral Sentiment: Analyst commentary remained generally optimistic overall, though one report noted Oppenheimer trimmed its price target to $225, which may limit enthusiasm somewhat. Veeva Systems (NYSE:VEEV) Price Target Lowered to $225.00 at Oppenheimer
• Negative Sentiment: One market recap said Veeva rose but still lagged the broader market, suggesting the move may reflect cautious trading rather than a decisive breakout. Veeva Systems (VEEV) Rises Yet Lags Behind Market: Some Facts Worth Knowing

Veeva Systems Trading Up 1.1%

VEEV opened at $165.10 on Thursday. The stock has a fifty day moving average price of $169.55 and a 200-day moving average price of $205.57. Veeva Systems Inc. has a 12 month low of $148.05 and a 12 month high of $310.50. The firm has a market cap of $26.96 billion, a price-to-earnings ratio of 30.52, a PEG ratio of 0.73 and a beta of 0.92.

Veeva Systems (NYSE:VEEV) last released its quarterly earnings results on Wednesday, March 4th. The technology company reported $2.06 EPS for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. Veeva Systems had a return on equity of 13.80% and a net margin of 28.44%.The company had revenue of $835.95 million during the quarter, compared to analysts’ expectations of $810.95 million. During the same period last year, the business posted $1.74 earnings per share. The firm’s revenue was up 16.0% compared to the same quarter last year. Veeva Systems has set its FY 2027 guidance at 8.850- EPS and its Q1 2027 guidance at 2.130-2.14 EPS. On average, equities research analysts forecast that Veeva Systems Inc. will post 6.41 EPS for the current year.

Wall Street Analyst Weigh In

VEEV has been the topic of several analyst reports. Citigroup downgraded Veeva Systems from a “buy” rating to a “neutral” rating and cut their target price for the company from $291.00 to $176.00 in a research report on Friday, April 10th. Royal Bank Of Canada dropped their price objective on Veeva Systems from $330.00 to $275.00 and set an “outperform” rating for the company in a report on Thursday, March 5th. Stifel Nicolaus boosted their price objective on Veeva Systems from $212.00 to $245.00 and gave the company a “buy” rating in a report on Thursday, March 5th. UBS Group boosted their price objective on Veeva Systems from $200.00 to $220.00 and gave the company a “neutral” rating in a report on Thursday, March 5th. Finally, Piper Sandler dropped their price objective on Veeva Systems from $355.00 to $285.00 and set an “overweight” rating for the company in a report on Thursday, March 5th. Sixteen analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Veeva Systems currently has a consensus rating of “Moderate Buy” and a consensus price target of $276.52.

Insider Buying and Selling

In other Veeva Systems news, Director Priscilla Hung sold 750 shares of the stock in a transaction dated Thursday, April 30th. The stock was sold at an average price of $155.64, for a total value of $116,730.00. Following the completion of the sale, the director directly owned 3,253 shares in the company, valued at approximately $506,296.92. This trade represents a 18.74% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 10.60% of the company’s stock.

Veeva Systems Profile

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.